Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma.
Algazi AP; Weber JS; Andrews SC; Urbas P; Munster PN; DeConti RC; Hwang J; Sondak VK; Messina JL; McCalmont T; Daud AI; British Journal Of Cancer, 2012, vol. 106, issue 1, p 85, ISSN 15321827. ISBN 15321827.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef